NIH Small Research Grant Program (Parent R03) (PA-20-200)

 
Inquiries:

NICHD Referral Office
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Email: [email protected]

The NICHD supports research in areas relevant to normal and abnormal human development, including contraception, fertilization, pregnancy, childbirth, prenatal and postnatal development; childhood development through adolescence; intellectual and developmental disabilities; and rehabilitation medicine.  Areas of Research. 

Grant applications and project proposals must fall within the missions of the scientific branches of NICHD's Division of Extramural Research or its National Center for Medical Rehabilitation Research. Potential applicants are strongly encouraged to visit these pages for recent scientific advances and emerging public health topics.

If you have questions about projects within a specific research area, you may find an NICHD program officer at Priorities.

Yuki Lama, PhD
Phone: 301-443-4577
[email protected]

 
The National Institute on Drug Abuse (NIDA) uses the Small Grant (R03) mechanism to provide support for projects requiring minimal funding for limited periods of time in any area relevant to the mission of the Institute as represented by its program areas. Examples of the types of projects supported by NIDA through the small grant mechanism include: Pilot or feasibility studies; development of research methodology; applied research; high risk/high payoff studies; development of new research technology; small-scale, self-contained projects; and analysis of existing datasets.

Only applications that fall within the scientific mission of the NINDS will be accepted and considered for funding by NINDS (NINDS Mission).

To assess the relevance of an application topic, applicants are strongly encouraged to contact NINDS program staff before submitting. A listing of NINDS program staff can be found at: Program Directors.

The National Institute of Neurological Disorders and Stroke (NINDS) uses the Small Grants Program (R03) to provide research support for new research projects in areas of high relevance to the mission of the NINDS (NINDS Mission). Priority will be given to applications in any of the following categories:
 
  

• Research projects leading to a defined product, resource or "deliverable" that has inherent value to the neuroscience community. Some examples include: creation of new animal models (e.g., mouse genetic models), generation of reagents (e.g., antibodies, RNAi, affinity capture reagents for use in a protein chip microarray), development of public resources (e.g., databases), development of cellular models for neurological disorders, development of novel phenotypic or behavioral screens for models of neurological disorders.
• Research projects that, regardless of whether they are hypothesis-driven, will generate an important and potentially publishable unit of information or dataset (either by itself or in combination with other data). Such projects should utilize a well-designed model of the normal or diseased nervous system. Some examples include: microarray gene expression analyses, proteomic analyses, pre-clinical drug screens.
• Research projects focused on secondary analysis of clinical data sets. This mechanism could also be appropriate for the collection of samples and/or associated clinical data to be included in the NINDS Genetics Repository (see: NINDS Human Genetics Resource Center ).

Priority will be given to research proposals that include a detailed plan for the sharing of resources and data generated under this award. Potential applicants are advised to contact program staff to verify that the proposed research is relevant to NINDS and responsive to one of the listed criteria. A complete listing of program director contacts may be found at:  NINDS Program Directors